> ## Content Index > Fetch the complete content index at: https://www.whiteroseintelligence.com/llms.txt > Use this file to discover other available public pages before exploring further. # 1st Global Consultation on SARS-CoV-2 Variants of Concern and the Impact on Public Health Interventions - URL: https://www.whiteroseintelligence.com/1st-global-consultation-on-sars-cov-2-variants-of-concern-and-the-impact-on-public-health-interventions/ - Published: 1999-01-01T08:03:00.000Z - Updated: 2024-12-31T07:09:37.000Z - Author: Liam Sturgess - Tags: Profiles, #docs The **1st Global Consultation on SARS-CoV-2 Variants of Concern and the Impact on Public Health Interventions** was a meeting held by the [World Health Organization](https://www.whiteroseintelligence.com/World-Health-Organization) (WHO) on March 29, 2021.\[1\] The event was followed by the [2nd Global Consultation on SARS-CoV-2 Variants of Concern and the Impact on Public Health Interventions](https://www.whiteroseintelligence.com/2nd-Global-Consultation-on-SARS-CoV-2-Variants-of-Concern-and-the-Impact-on-Public-Health-Interventions) on June 10, 2021.\[2\] ## Participants | Name | Affiliation | Topic | | ---------------------------------------------------------------- | ----------------------------------------------------------------------------------------------------------------------------------------------- | ------------------------------------------------------------------------------------------------------------------------------------------- | | Michael Ryan | [World Health Organization](https://www.whiteroseintelligence.com/World-Health-Organization) | Opening remarks | | Sylvie Briand | [World Health Organization](https://www.whiteroseintelligence.com/World-Health-Organization) | WHO framework for monitoring & assessing SARS-CoV-2 variants | | **Session 1: Focus on SARS-CoV-2 Variants** | | | | Maria Van Kerkhovea | [World Health Organization](https://www.whiteroseintelligence.com/World-Health-Organization) | Moderator | | Boris Pavlin | [World Health Organization](https://www.whiteroseintelligence.com/World-Health-Organization) | Epi update on SARS-CoV-2 variants of concern | | Frank Konings | [World Health Organization](https://www.whiteroseintelligence.com/World-Health-Organization) | Status of assessment of mutations, VOI and VOC in terms of understanding transmissibility, severity and potential impact on countermeasures | | Volker Thiel | University of Bern | How WHO assesses knowledge and knowledge gaps and develops advice and guidance | | Janet Diaz | [World Health Organization](https://www.whiteroseintelligence.com/World-Health-Organization) | \- | | April Baller | [World Health Organization](https://www.whiteroseintelligence.com/World-Health-Organization) | \- | | **Session 2: Framework of Evidence for the SARS-CoV-2 Variants** | | | | Wenqing Zhang | [World Health Organization](https://www.whiteroseintelligence.com/World-Health-Organization) | Moderator | | John McCauley | Francis Crick Institute | Experience from influenza: vaccine virus selection system and risk assessment framework | | Richard Webby | St. Jude Children's Research Hospital | Experience from influenza: vaccine virus selection system and risk assessment framework | | Ana Maria Henao Restrepo | R&D Blueprint, [World Health Organization](https://www.whiteroseintelligence.com/World-Health-Organization) | Moderator | | Philip Krause | [Food and Drug Administration](https://www.whiteroseintelligence.com/Food-and-Drug-Administration) (FDA) | Building a framework of evidence for the monitoring and assessment of vaccines in the context of SARS-CoV-2 variants | | Kanta Subbarao | Peter Doherty Institute for Infection and Immunity | Moderator | | Jakob Cramer | [Coalition for Epidemic Preparedness Innovations](https://www.whiteroseintelligence.com/Coalition-for-Epidemic-Preparedness-Innovations) (CEPI) | Structured Debate introduced by Ana Maria Henao Restrepo | | Paul Fine | London School of Hygiene and Tropical Medicine | Structured Debate introduced by Ana Maria Henao Restrepo | | Thomas Fleming | University of Washington | Structured Debate introduced by Ana Maria Henao Restrepo | | Alan Khoo | International Medical University | Structured Debate introduced by Ana Maria Henao Restrepo | | Ira Longini | University of Florida | Structured Debate introduced by Ana Maria Henao Restrepo | | Cesar Muñoz-Fontela | R&D Blueprint, [World Health Organization](https://www.whiteroseintelligence.com/World-Health-Organization) | Structured Debate introduced by Ana Maria Henao Restrepo | | Richard Neher | University of Basel | Structured Debate introduced by Ana Maria Henao Restrepo | | Jerome Singh | University of KwaZulu-Natal | Structured Debate introduced by Ana Maria Henao Restrepo | | David Wentworth | [Centers for Disease Control and Prevention](https://www.whiteroseintelligence.com/Centers-for-Disease-Control-and-Prevention) (CDC) | Structured Debate introduced by Ana Maria Henao Restrepo | | **Session 3: Impact on Public Health Decision-Making** | | | | Katherine O'Brien | [World Health Organization](https://www.whiteroseintelligence.com/World-Health-Organization/) | Moderator | | Soumya Swaminathan | [World Health Organization](https://www.whiteroseintelligence.com/World-Health-Organization) | Interplay between vaccine supply, vaccine performance, and emergence of SARS-CoV-2 variants | | Sarah Cobey | University of Chicago | Interplay between vaccine supply, vaccine performance, and emergence of SARS-CoV-2 variants | | Annelies Wilder-Smith | [World Health Organization](https://www.whiteroseintelligence.com/World-Health-Organization) | Interplay between vaccine supply, vaccine performance, and emergence of SARS-CoV-2 variants | | Rogerio Gaspar | [World Health Organization](https://www.whiteroseintelligence.com/World-Health-Organization) | Moderator | | Philip Krause | [Food and Drug Administration](https://www.whiteroseintelligence.com/Food-and-Drug-Administration) (FDA) | Perspectives from regulators and developers | | Adam Hacker | [Coalition for Epidemic Preparedness Innovations](https://www.whiteroseintelligence.com/Coalition-for-Epidemic-Preparedness-Innovations) (CEPI) | Perspectives from regulators and developers | | Boitumelo Semete | South African Health Products Regulatory Authority (SAHPRA) | Perspectives from regulators and developers | | V.G. Somani | Central Drugs Standard Control Organisation (CDSCO) | Perspectives from regulators and developers | | David Heymann | Strategic and Technical Advisory Group on Infectious Hazards with Pandemic and Epidemic Potential (STAG-IH) | Impact on public health decision-making | | Alejandro Cravioto | Strategic Advisory Group of Experts on Immunization (SAGE) | Impact on public health decision-making | --- 1. *Global Consultation on a Decision Framework for Assessing the Impact of SARS-CoV-2 Variants of Concern on Public Health Interventions.* (2021, March 29). World Health Organization. ↩︎ 2. *2nd Global Consultation on SARS-CoV-2 Variants of Concern and the Impact on Public Health Interventions.* (2021). World Health Organization. ↩︎